'Irish drug approvals remain turgid with little transparency'
The knowledge that treatment exists, but isn’t available to you, is likely to become more common, writes Susan Mitchell
As pharma companies in Ireland grow impatient over our lethargic and bureaucratic medicine approvals process, their counterparts in the UK are going to court in an attempt to stop the NHS from imposing new limits on the price it will pay for medicines.
Independent journalism every day
With digital access you can read The Business Post whenever, wherever, and however you want.
- Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
- Breaking news, comment and analysis from the best Business Post writers seven days a week.
- Live blogs of major news events
- Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
- Access to The Business Post's extensive archive
